The White House Office of Management and Budget (OMB) recently proposed a rewrite of the Guidance for Federal Financial Assistance, updating regulations that dictate reporting and performance requirements for federal grant recipients. The proposed rule implements many of the changes President Trump announced in an executive order, Improving Oversight of Federal Grantmaking, last August. Some of the most significant impacts of the OMB federal grant guidance are expected to fall on the U.S. Department of Health and Human Services, where biomedical research agencies like the National Institutes of Health and important diabetes research and education programs at the Centers for Disease Control and Prevention are housed.
The American Diabetes Association® is extremely concerned with the potential impact of the OMB’s proposed rule to reshape the federal grantmaking process for the second time in as many years. We support efforts to make the federal grant process more transparent, however, this new guidance politicizes federal financial assistance and creates uncertainty for the biomedical research community. Additionally, mandating use of the E-Verify system and new English language requirements could create unnecessary administrative burdens for grant recipients. Allowing political appointees to determine whether a grant recipient is complying with administration policies and empowering them with the authority to terminate grants based on vague performance measures could have long-term consequences for vital biomedical research, including research dedicated to preventing, treating, and finding a cure for diabetes.
###
About the American Diabetes Association
The American Diabetes Association (ADA) is the nation’s leading voluntary health organization fighting to end diabetes and helping people thrive. This year, the ADA celebrates 85 years of driving discovery and research to prevent, manage, treat, and ultimately cure diabetes—and we’re not stopping. There are over 155 million Americans living with diabetes or prediabetes. Through advocacy, program development, and education, we’re fighting for them all. To learn more or to get involved, visit us at or call 1-800-DIABETES (800-342-2383). Join us in the fight on Facebook (American Diabetes Association), Spanish Facebook (Asociación Americana de la Diabetes), LinkedIn (American Diabetes Association), and Instagram (@AmDiabetesAssn). To learn more about how we are advocating for everyone affected by diabetes, visit us on X (@AmDiabetesAssn).
